<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Dube K</submitter><funding>NIAID NIH HHS</funding><pagination>120-135</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9519804</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>23(1)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>People with HIV (PWH) and community members have advocated for the development of a home-based viral load test device that could make analytical treatment interruptions (ATIs) less burdensome.&lt;h4>Objective&lt;/h4>We assessed community acceptability of a novel home-based viral load test device.&lt;h4>Methods&lt;/h4>In 2021, we conducted 15 interviews and 3 virtual focus groups with PWH involved in HIV cure research. We used conventional thematic analysis to analyze the data.&lt;h4>Results&lt;/h4>PWH viewed the home-based viral load test device as a critical adjunct in ongoing HIV cure trials with ATIs. The ability to test for viral load at home on demand would alleviate anxiety around being off ART. Participants drew parallels with glucometers used for diabetes. A preference was express</pubmed_abstract><journal>HIV research &amp; clinical practice</journal><pubmed_title>"We are looking at the future right now": community acceptability of a home-based viral load test device in the context of HIV cure-related research with analytical treatment interruptions in the United States.</pubmed_title><pmcid>PMC9519804</pmcid><funding_grant_id>UM1 AI164570</funding_grant_id><pubmed_authors>Lynn KM</pubmed_authors><pubmed_authors>Evans BR</pubmed_authors><pubmed_authors>Tebas P</pubmed_authors><pubmed_authors>Rosenbloom D</pubmed_authors><pubmed_authors>Bateman K</pubmed_authors><pubmed_authors>Shipley L</pubmed_authors><pubmed_authors>Kanazawa J</pubmed_authors><pubmed_authors>Carter WB</pubmed_authors><pubmed_authors>Peterson B</pubmed_authors><pubmed_authors>Johnson S</pubmed_authors><pubmed_authors>Hazuda DJ</pubmed_authors><pubmed_authors>Hiserodt E</pubmed_authors><pubmed_authors>Lalley-Chareczko L</pubmed_authors><pubmed_authors>Kim S</pubmed_authors><pubmed_authors>Anderson M</pubmed_authors><pubmed_authors>Dube K</pubmed_authors><pubmed_authors>Howell BJ</pubmed_authors><pubmed_authors>Montaner LJ</pubmed_authors><pubmed_authors>Roebuck C</pubmed_authors><pubmed_authors>Mounzer K</pubmed_authors><pubmed_authors>Dee L</pubmed_authors></additional><is_claimable>false</is_claimable><name>"We are looking at the future right now": community acceptability of a home-based viral load test device in the context of HIV cure-related research with analytical treatment interruptions in the United States.</name><description>&lt;h4>Background&lt;/h4>People with HIV (PWH) and community members have advocated for the development of a home-based viral load test device that could make analytical treatment interruptions (ATIs) less burdensome.&lt;h4>Objective&lt;/h4>We assessed community acceptability of a novel home-based viral load test device.&lt;h4>Methods&lt;/h4>In 2021, we conducted 15 interviews and 3 virtual focus groups with PWH involved in HIV cure research. We used conventional thematic analysis to analyze the data.&lt;h4>Results&lt;/h4>PWH viewed the home-based viral load test device as a critical adjunct in ongoing HIV cure trials with ATIs. The ability to test for viral load at home on demand would alleviate anxiety around being off ART. Participants drew parallels with glucometers used for diabetes. A preference was express</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Dec</publication><modification>2025-04-21T23:25:14.151Z</modification><creation>2025-04-05T19:06:20.248Z</creation></dates><accession>S-EPMC9519804</accession><cross_references><pubmed>35348047</pubmed></cross_references></HashMap>